27804215|t|Simultaneously Targeting Myofibroblast Contractility and Extracellular Matrix Cross-Linking as a Therapeutic Concept in Airway Fibrosis
27804215|a|Fibrosis after solid organ transplantation is considered an irreversible process and remains the major cause of graft dysfunction and death with limited therapies. This remodeling is characterized by aberrant accumulation of contractile myofibroblasts that deposit excessive extracellular matrix (ECM) and increase tissue stiffness. Studies demonstrate, however, that a stiff ECM itself promotes fibroblast -to- myofibroblast differentiation, stimulating further ECM production. This creates a positive feedback loop that perpetuates fibrosis. We hypothesized that simultaneously targeting myofibroblast contractility with relaxin and ECM stiffness with lysyl oxidase inhibitors could break the feedback loop, reversing established fibrosis. To test this, we used the orthotopic tracheal transplantation (OTT) mouse model, which develops robust fibrotic airway remodeling. Mice with established fibrosis were treated with saline, mono-, or combination therapies. Although monotherapies had no effect, combining these agents decreased collagen deposition and promoted re-epithelialization of remodeled airways. Relaxin inhibited myofibroblast differentiation and contraction in a matrix - stiffness - dependent manner through prostaglandin E2 (PGE2). Furthermore, the effect of combination therapy was lost in PGE2 receptor knockout and PGE2 - inhibited OTT mice. This study revealed the important synergistic roles of cellular contractility and tissue stiffness in the maintenance of fibrotic tissue and suggests a new therapeutic principle for fibrosis.
27804215	0	14	Simultaneously	T079	C0521115
27804215	15	24	Targeting	T169	C1521840
27804215	25	52	Myofibroblast Contractility	T043	C4235370
27804215	57	77	Extracellular Matrix	T024	C0015350
27804215	78	91	Cross-Linking	T169	C0332220
27804215	97	116	Therapeutic Concept	T169	C0302350
27804215	120	126	Airway	T023	C0458827
27804215	127	135	Fibrosis	T046	C0016059
27804215	136	144	Fibrosis	T046	C0016059
27804215	151	178	solid organ transplantation	T061	C0029216
27804215	196	208	irreversible	T079	C0205355
27804215	209	216	process	T067	C1522240
27804215	233	238	major	T080	C0205164
27804215	248	265	graft dysfunction	T046	C1167870
27804215	270	275	death	T040	C0011065
27804215	281	288	limited	T169	C0439801
27804215	289	298	therapies	T061	C0087111
27804215	305	315	remodeling	UnknownType	C0678692
27804215	319	332	characterized	T052	C1880022
27804215	336	344	aberrant	T080	C0443127
27804215	345	357	accumulation	T033	C4055506
27804215	361	387	contractile myofibroblasts	T025	C0225360
27804215	393	400	deposit	T169	C0333562
27804215	401	410	excessive	T080	C0442802
27804215	411	431	extracellular matrix	T024	C0015350
27804215	433	436	ECM	T024	C0015350
27804215	442	450	increase	T169	C0442805
27804215	451	467	tissue stiffness	T184	C2017125
27804215	469	476	Studies	T062	C2603343
27804215	506	511	stiff	T184	C0427008
27804215	512	515	ECM	T024	C0015350
27804215	523	531	promotes	T052	C0033414
27804215	532	542	fibroblast	T025	C0016030
27804215	548	561	myofibroblast	T025	C0225360
27804215	562	577	differentiation	T043	C0007589
27804215	579	590	stimulating	T052	C1879547
27804215	599	602	ECM	T024	C0015350
27804215	603	613	production	T052	C1883254
27804215	630	652	positive feedback loop	UnknownType	C0678664
27804215	658	669	perpetuates	T080	C0205556
27804215	670	678	fibrosis	T046	C0016059
27804215	683	695	hypothesized	T078	C1512571
27804215	701	715	simultaneously	T079	C0521115
27804215	716	725	targeting	T169	C1521840
27804215	726	753	myofibroblast contractility	T043	C4235370
27804215	759	766	relaxin	T116,T121,T125	C0035031
27804215	771	774	ECM	T024	C0015350
27804215	775	784	stiffness	T184	C0427008
27804215	790	803	lysyl oxidase	T116,T126	C0024375
27804215	804	814	inhibitors	T121	C0014432
27804215	831	844	feedback loop	T039	C0678663
27804215	846	855	reversing	T169	C1555029
27804215	856	867	established	T080	C0443211
27804215	868	876	fibrosis	T046	C0016059
27804215	881	885	test	T169	C0039593
27804215	904	939	orthotopic tracheal transplantation	T061	C0040732
27804215	941	944	OTT	T061	C0040732
27804215	946	957	mouse model	T050	C2986594
27804215	974	980	robust	T080	C2986815
27804215	981	989	fibrotic	T169	C0334129
27804215	990	996	airway	T023	C0458827
27804215	997	1007	remodeling	UnknownType	C0678692
27804215	1009	1013	Mice	T015	C0025929
27804215	1019	1030	established	T080	C0443211
27804215	1031	1039	fibrosis	T046	C0016059
27804215	1045	1052	treated	T169	C1522326
27804215	1058	1064	saline	T167	C0036082
27804215	1066	1071	mono-	T061	C0520016
27804215	1076	1097	combination therapies	T061	C0013218
27804215	1108	1121	monotherapies	T061	C0520016
27804215	1126	1135	no effect	T080	C1301751
27804215	1137	1159	combining these agents	T121	C0013162
27804215	1160	1169	decreased	T081	C0205216
27804215	1170	1178	collagen	T116	C0009325
27804215	1179	1189	deposition	T169	C0333562
27804215	1194	1202	promoted	T052	C0033414
27804215	1203	1223	re-epithelialization	T042	C0334221
27804215	1227	1244	remodeled airways	T033	C2717792
27804215	1246	1253	Relaxin	T116,T121,T125	C0035031
27804215	1254	1263	inhibited	T080	C0311403
27804215	1264	1277	myofibroblast	T025	C0225360
27804215	1278	1293	differentiation	T043	C0007589
27804215	1298	1309	contraction	T046	C1140999
27804215	1315	1321	matrix	T024	C0015350
27804215	1324	1333	stiffness	T184	C0427008
27804215	1336	1345	dependent	T169	C3244310
27804215	1361	1377	prostaglandin E2	T109	C3813211
27804215	1379	1383	PGE2	T109	C3813211
27804215	1403	1409	effect	T080	C1280500
27804215	1413	1432	combination therapy	T061	C0013218
27804215	1445	1458	PGE2 receptor	T116,T192	C0034835
27804215	1459	1467	knockout	T015	C0206745
27804215	1472	1476	PGE2	T109	C3813211
27804215	1479	1488	inhibited	T080	C0311403
27804215	1489	1492	OTT	T061	C0040732
27804215	1493	1497	mice	T015	C0025929
27804215	1504	1509	study	T062	C2603343
27804215	1510	1518	revealed	T080	C0443289
27804215	1533	1544	synergistic	T080	C2986495
27804215	1545	1550	roles	T077	C1705810
27804215	1554	1576	cellular contractility	T046	C1140999
27804215	1581	1597	tissue stiffness	T184	C2017125
27804215	1605	1616	maintenance	T052	C0024501
27804215	1620	1628	fibrotic	T169	C0334129
27804215	1629	1635	tissue	T024	C0040300
27804215	1655	1666	therapeutic	T169	C0302350
27804215	1667	1676	principle	UnknownType	C0678989
27804215	1681	1689	fibrosis	T046	C0016059